Ryan Braun’s PED suspension appeal was heard Thursday

45 Comments

Brewers outfielder Ryan Braun finally got his day in court on Thursday afternoon. Here’s the story, from reporters Bill Madden, Andy Martino and Teri Thompson of the New York Daily News:

Ryan Braun, the National League’s Most Valuable Player, pleaded his case Thursday before a three-member panel that will decide whether he faces a 50-game suspension for testing positive for elevated levels of testosterone.

The appeal came just two days before Braun will accept his MVP award at the New York Chapter of the Baseball Writers’ Association of America’s dinner Saturday night at the New York Hilton, sources familiar with Braun told the Daily News.

The panel, made up of MLB Players Association executive director Michael Weiner, MLB executive vice president for labor relations Rob Manfred and independent arbitrator Shyam Das, is not expected to reach a decision before Braun accepts his award. But our guess would be that it won’t take more than a week.

Braun is maintaining a cry of innocence, but that early-October PED test showed insanely high levels of synthetic testosterone in his bloodstream and you have to wonder how he could possibly attempt to prove that it wasn’t ever there. Calling the test result a false-positive isn’t going to cut it, and arguing that something non performance-enhancing triggered the positive reading would require a whole lot of convincing.

Report: Nathan Eovaldi drawing interest from at least nine teams

Nathan Eovaldi
Getty Images
1 Comment

Former Red Sox right-hander Nathan Eovaldi is up for grabs this offseason, and Nick Cafardo of the Boston Globe says that as many as nine suitors are interested in bringing the righty aboard. While the Red Sox are eager to retain Eovaldi’s services after his lights-out performance during their recent postseason run, they’ll have to contend with the Brewers, Phillies, Braves, White Sox, Padres, Blue Jays, Giants, and Angels — all of whom are reportedly positioned to offer something for the starter this winter.

It wasn’t all smooth sailing for the 28-year-old in 2018, however. After losing his 2017 season to Tommy John surgery, he underwent an additional procedure to remove loose bodies from his right elbow in March and didn’t make his first appearance until the end of May. He was flipped for lefty reliever Jalen Beeks just prior to the trade deadline and finished his season with a combined 6-7 record in 21 starts, a 3.81 ERA, 1.6 BB/9, and 8.2 SO/9 through 111 innings.

Despite his numerous health issues over the last few years, Eovaldi raised his stock in October after becoming a major contributor during the Red Sox’ championship run. He contributed two quality starts in the ALDS and ALCS and returned in Games 1-3 of the World Series with three lights-out performances in relief — including a six-inning effort in the 18-inning marathon that was Game 3.

A frontrunner has yet to emerge for the righty this offseason, but Cafardo points out that the nine teams listed so far might just be the tip of the iceberg. Still, he won’t be the most sought-after starter on the market, as former Diamondbacks southpaw Patrick Corbin is expected to command an even bigger payday following his career-best 6.0-fWAR performance in 2018.